Amring Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMRING PHARMS, and what generic alternatives to AMRING PHARMS drugs are available?
AMRING PHARMS has fourteen approved drugs.
There are eight US patents protecting AMRING PHARMS drugs.
There are eight patent family members on AMRING PHARMS drugs in two countries and twenty-nine supplementary protection certificates in ten countries.
Summary for Amring Pharms
| International Patents: | 8 |
| US Patents: | 8 |
| Tradenames: | 13 |
| Ingredients: | 13 |
| NDAs: | 14 |
Drugs and US Patents for Amring Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amring Pharms | LYSTEDA | tranexamic acid | TABLET;ORAL | 022430-001 | Nov 13, 2009 | AB | RX | Yes | Yes | 8,957,113 | See Plans and Pricing | Y | See Plans and Pricing | ||
| Amring Pharms | LYSTEDA | tranexamic acid | TABLET;ORAL | 022430-001 | Nov 13, 2009 | AB | RX | Yes | Yes | 8,809,394 | See Plans and Pricing | Y | See Plans and Pricing | ||
| Amring Pharms | LYSTEDA | tranexamic acid | TABLET;ORAL | 022430-001 | Nov 13, 2009 | AB | RX | Yes | Yes | 8,273,795 | See Plans and Pricing | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for AMRING PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 650 mg | ➤ Subscribe | 2011-05-24 |
International Patents for Amring Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2011168596 | See Plans and Pricing |
| World Intellectual Property Organization (WIPO) | 2006023000 | See Plans and Pricing |
| Japan | 2008508276 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Amring Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1586316 | 132011901975261 | Italy | See Plans and Pricing | PRODUCT NAME: BROMFENAC(YELLOX); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/11/692/001, 20110518 |
| 1429780 | 132013902137451 | Italy | See Plans and Pricing | PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106 |
| 1586316 | 2011C/027 | Belgium | See Plans and Pricing | PRODUCT NAME: BROMFENAC; AUTHORISATION NUMBER AND DATE: EU/1/11/692/001 20110523 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
